CTSDMC PPMI Stat Core Team
CTSDMC PPMI DMC Team
About PPMI
The Parkinson's Progression Markers Initiative (PPMI), funded by the Michael J. Fox Foundation, is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biological sampling and clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression. The mission of PPMI is to identify one or more biomarkers of Parkinson's disease progression. The discovery of a biomarker is a critical step in the development of new and better treatments for Parkinson's Disease.
The CTSDMC is the Data Management Core of PPMI as well as the Statistical Core of PPMI, leading the statistical analyses on the PPMI data and samples.
Top 2
Pick for discoveries in Movement Disorders in Neurology Today
2
Discussion articles in Neurology Today
© 2023 – The Michael J. Fox Foundation – https://www.michaeljfox.org/ – All Rights Reserved.
U.S. and Canada Clinic Locations
The PPMI study currently has 30 active sites in the United States and 3 in Canada.
International Clinic Locations
In addition to the 30 U.S. sites and 3 Canadian sites, the PPMI Study has 17 International sites including a site in Lagos, Nigeria.
MJFF
In 2023, the CTSDMC PPMI Statistical Core Team, along with our PPMI collaborators, made a momentous discovery in Parkinson's Disease. A biomarker was found that could aid in the diagnosis of Parkinson's.
© 2023 – The Michael J. Fox Foundation – https://www.michaeljfox.org/ – All Rights Reserved.